Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New ER modulators presented by Ortho-McNeil researchers

Feb. 20, 2004

EGFR pharmDx kit receives FDA approval

Feb. 19, 2004

ImmunoGen describes anti-Muc1 and Muc16 antibodies and their therapeutic use

Feb. 19, 2004

Preliminary phase III data suggests therapeutic benefits for Dacogen(TM) in MDS

Feb. 19, 2004

Fasgen and Johns Hopkins U. researchers claim agents for FAS, NPY and CPT-1-mediated disorders

Feb. 18, 2004

Novel KDR inhibitors prepared and tested by Amgen researchers

Feb. 18, 2004

AxyS claims new caspase activators and their use in cancer and other disorders

Feb. 18, 2004

Ariad highlights AP-23573 product development progress over past year

Feb. 18, 2004

Xenova studies selective MRP1 inhibitors for multidrug resistance in cancer

Feb. 18, 2004

Erbitux receives FDA approval

Feb. 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...